Teresa Young

Teresa Young

Corporate Officer/Principal chez
Women in Bio, Inc.

Fortune : 67 515 $ au 30/06/2026

59 ans
Health Technology
Commercial Services
Consumer Services

Profil

Teresa L.
Young
is currently a Member at Healthcare Businesswomens Association and a Member at Women in Bio, Inc. Formerly, Dr. Young was EVP, Chief Commercial & Strategy Officer at Seres Therapeutics, Inc., Vice President-Global Commercial Strategy at SAGE Therapeutics, Inc. from 2018 to 2020, and Vice President & General Manager-Cardiovascular at Bristol Myers Squibb Co. from 2010 to 2018.
Dr. Young completed undergraduate and doctorate degrees at the University of South Carolina.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
13/04/2026 8 557 ( 0,09 % ) 67 515 $ 30/06/2026

Postes actifs de Teresa Young

SociétésPosteDébut
Corporate Officer/Principal -
Corporate Officer/Principal -

Anciens postes connus de Teresa Young

SociétésPosteFin
SAGE THERAPEUTICS, INC. Corporate Officer/Principal 01/06/2020
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 01/03/2018
SERES THERAPEUTICS, INC. Corporate Officer/Principal -
Voir l'expérience en détail de Teresa Young

Formation de Teresa Young

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

91

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Health Technology

Commercial Services

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Teresa Young
🔇